RUSH ProtocolNCT06361225
Routine Use of RUSH Protocol in the Intensive Care Unit
An observational study of RUSH Protocol, run by Meir Medical Center at 1 site in Israel.
Trial summary
The RUSH protocol has been used for several years for the rapid evaluation of a patient admitted to the emergency room with shock. Traditionally, its use was especially common in trauma victims, but later its use was extended to patients admitted to the emergency room with shock from any reason. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- RUSH Protocol
- What is being tested?
- evaluation with RUSH protocol
- How many people
- 50 participants
- Where
- 1 siteIsrael
- Study dates
- 1 Dec 2024to 1 Aug 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.
Who may be able to join
- Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.
- Exclusion Criteria:Patients who were not evaluated using the RUSH protocol or for whom data were missing.
- -
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Routine Use of RUSH Protocol in the Intensive Care Unit- Does it Influence Patient Management? Prospective Observational Study
The RUSH protocol has been used for several years for the rapid evaluation of a patient admitted to the emergency room with shock. Traditionally, its use was especially common in trauma victims, but later its use was extended to patients admitted to the emergency room with shock from any reason. The protocol includes rapid assessment with the guideness of ultrasound of heart contraction, assessment for pleural effusions, assessment of intra-abdominal blood (FAST), diagnosis of venous thrombosis (DVT), and rulling out hydronephrosis. It can also add a pupil size assessment and an evaluation of the gallbladder and bile ducts, as well as the size of the bladder. In intensive care, we use this protocol (or part of it) for the evaluation of a patient who is deteriorating in the ICU for an unknown reason . In some patients we use this protocol as a routine part of the physical examination as part of the daily patient evaluation.
We would like to investigate whether the routine use of the RUSH protocol as part of the daily patient evaluation in the general intensive care unit will lead to any change in the patient's management.
- Conditions
- RUSH Protocol
- Being tested
- evaluation with RUSH protocol
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
evaluation with RUSH protocolDiagnostic test
Daily evaluation of the patient via ultrasound using the RUSH protocol
What is being measured
The primary outcome is the main question the study is designed to answer.
Change of patient medical therapy
Adding a new medical therapy= yes/no (1/0), changing the dose of an existing medical therapy (increase/decrease=1/0)
Measured: from day 0 to day 3 of performing the RUSH protocol
Performing unplanned laboratory tests
Performing unplanned laboratory tests as a result of the RUSH protocol- yes/no (=1/0)
Measured: from day 0 to day 3 of performing the RUSH protocol
Performing unplanned image tests
Performing unplanned image tests (CXR, CT etc.) as a result of the RUSH protocol- yes/no (=1/0)
Measured: from day 0 to day 3 of performing the RUSH protocol
Performing unplanned invasive procedure
Performing unplanned invasive procedure (surgery, minimally invasive procedure)- yes/no (1/0)
Measured: from day 0 to day 3 of performing the RUSH protocol
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2024
- Study start1 Dec 2024
- Primary completion1 Aug 2025
- Study completion1 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for RUSH ProtocolStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Meir Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, sara dichtwald, Meir Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06361225
- Sponsor's protocol ID
- 0075-24-MMC
- Status last verified
- Oct 2026
- First submitted
- 31 Mar 2024
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Routine Use of RUSH Protocol in the Intensive Care Unit- Does it Influence Patient Management? Prospective Observational Study
- ClinicalTrials.gov ID
- NCT06361225
- Acronym / sponsor ID
- 0075-24-MMC
- Conditions
- RUSH Protocol
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Meir Medical CenterUniversity, hospital or other
- Study start
- 1 Dec 2024 (actual)
- Primary completion
- 1 Aug 2025 (actual)
- Study completion
- 1 Aug 2025 (actual)
- First posted
- 11 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The RUSH protocol has been used for several years for the rapid evaluation of a patient admitted to the emergency room with shock. Traditionally, its use was especially common in trauma victims, but later its use was extended to patients admitted to the emergency room with shock from any reason. The protocol includes rapid assessment with the guideness of ultrasound of heart contraction, assessment for pleural effusions, assessment of intra-abdominal blood (FAST), diagnosis of venous thrombosis (DVT), and rulling out hydronephrosis. It can also add a pupil size assessment and an evaluation of the gallbladder and bile ducts, as well as the size of the bladder. In intensive care, we use this protocol (or part of it) for the evaluation of a patient who is deteriorating in the ICU for an unknown reason . In some patients we use this protocol as a routine part of the physical examination as part of the daily patient evaluation.
We would like to investigate whether the routine use of the RUSH protocol as part of the daily patient evaluation in the general intensive care unit will lead to any change in the patient's management.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.
Key inclusion criteria (3 listed)
- Patients who were admitted to the intensive care unit for any reason and were evaluated daily using the RUSH protocol.
- Exclusion Criteria:Patients who were not evaluated using the RUSH protocol or for whom data were missing.
- -
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| evaluation with RUSH protocolDaily evaluation of the patient via ultrasound using the RUSH protocol | Diagnostic test | – |
Primary outcome
Change of patient medical therapy
Time frame: from day 0 to day 3 of performing the RUSH protocol
Adding a new medical therapy= yes/no (1/0), changing the dose of an existing medical therapy (increase/decrease=1/0)
Performing unplanned laboratory tests
Time frame: from day 0 to day 3 of performing the RUSH protocol
Performing unplanned laboratory tests as a result of the RUSH protocol- yes/no (=1/0)
Performing unplanned image tests
Time frame: from day 0 to day 3 of performing the RUSH protocol
Performing unplanned image tests (CXR, CT etc.) as a result of the RUSH protocol- yes/no (=1/0)
Performing unplanned invasive procedure
Time frame: from day 0 to day 3 of performing the RUSH protocol
Performing unplanned invasive procedure (surgery, minimally invasive procedure)- yes/no (1/0)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for RUSH Protocol
RecruitingPhase 2/3
Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study
Food Allergy in Children, Milk Allergy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of RUSH Protocol, run by Meir Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change of patient medical therapy (time frame: from day 0 to day 3 of performing the RUSH protocol). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.